News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The use of machine learning to characterise the tumour-immune microenvironment – EORTC
EORTC/LinkedIn
Mar 15, 2025, 03:26

The use of machine learning to characterise the tumour-immune microenvironment – EORTC

EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:

“New advancements in breast cancer research!

Our latest publication explores the use of machine learning to characterise the tumour-immune microenvironment in the EORTC 10994/BIG 1-00 trial.

Discover how AI is helping us understand immune infiltrates and their prognostic implications.“

The use of machine learning to characterise the tumour-immune microenvironment - EORTC

Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trial.

Authors: Ioannis Zerdes, et al.

The use of machine learning to characterise the tumour-immune microenvironment - EORTC

AI Breast Cancer cancer EORTC European Organisation for Research and Treatment of Cancer fight against cancer Global fight against cancer OncoDaily Oncology
Special Coverage
Insight
Aug 13, 2025, 15:36
Dora Vallejo-Ardila: Highlights from First Day of MOGA 2025
Voices
Aug 13, 2025, 15:34
Sameer Keole: Privilege of Being ASTRO President Is Meeting Talented People I’d Not Met Otherwise
Voices
Aug 13, 2025, 15:32
Diana Adams: Medical Oncology Group of Australia (MOGA)⁩ Session on Increasing Workforce Pressure
Voices
Aug 13, 2025, 15:30
Proud to be No.1 in Hypertension and No.6 in Cardiology Worldwide - Servier
Voices
Aug 13, 2025, 15:29
Stefano Magno: Integrative Oncology Teams to Bridge Oncology and Primary Care
Science
Aug 13, 2025, 15:26
Arndt Vogel: Interesting Analysis on Potential Biomarkers to Guide Adjuvant Treatment
Voices
Aug 13, 2025, 15:25
Yvonne Diaz: Survival Rates for the Deadliest Cancers
Insight
Aug 13, 2025, 15:20
Amol Akhade: KEYNOTE-905 - Potential Practice Changer in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Blog Posts
Aug 13, 2025, 15:18
Ryan Nipp: Patient-Reported Symptoms Linked to Emergency Care in Chemotherapy
Insight
Aug 13, 2025, 15:15
Stephen V Liu: Comparison of EGFR NSCLC Transformed to SCLC vs de novo SCLC
Insight
Aug 13, 2025, 15:14
New FDA PreCheck Program to Boost U.S. Drug Manufacturing
Voices
Aug 13, 2025, 15:10
Jia (Jenny) Liu: Wonderful to Kickoff the MOGA25 Annual Meeting in Melbourne